DNA antisense strategies in the study of receptors for vasoactive peptides, and of growth and wound-healing factors

Molecular and Cellular Biochemistry

Volumn 172, Issue 1-2, 1997, Pages 199-211

  D'Orleans Juste R ^a   Sirois, M G ^b   Edelman, E R ^b   Regoli, D ^a   Pheng, L H ^a   Bkaily, G ^a   Lindsey, C J ^c  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

c myc and c myb protooncogenes; DNA antisense; ET(A) and B1 receptors; Oligophosphodiester; Oligophosphorothioate; PDGF receptor subunit

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ENDOTHELIN RECEPTOR; KININ; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ARTICLE; CELL GROWTH; ONCOGENE C MYB; ONCOGENE C MYC; WOUND HEALING;

EID: 8544245711     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006800629012     Document Type: Article

References (77)

1. Regoli D, Boudon A, Fauchère J.-L: Receptors and antagonists for substance P and related peptides. Pharmacol Rev 46: 450-499, 1994
2. Hess JF, Borkowski JA, Young GS, Strader CD, Ransom RW: Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Comm 184: 260-268, 1992
3. 1. Genomics 31: 51-57, 1996
4. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732, 1990
5. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T: Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735, 1990
6. Betsholtz C: Role of platelet-derived growth factors in mouse development. Int J Develop Biol 39: 817-825, 1995
7. Rosbash M, Singer RH: RNA travel: tracks from DNA to cytoplasm. Cell 75: 399-401, 1993
8. Gurthie C: Messenger RNA splicing in yeast: clues to why the spliceosome is a ribonucleoprotein. Science 253: 157-163, 1991
9. Dargemont C, Kuhn LC: Export of mRNA from microinjected nuclei of xenopus laevis oocytes. J Cell Biol 118: 1-9, 1992
10. McCarthy JEG, Kollmus H: Cytoplasmic mRNA-protein interactions in eukaryotic gene expression. Trends Biochem Sci 20: 191-197, 1995
11. Blake KR, Murakami A, Miller PS: Inhibition of rabbit globin mRNA translation by sequence specific oligodeoxynucleotides. Biochemistry 24: 6132-6138, 1985
12. Anderson KP, Fox MC, Browndriver V, Martin MJ, Azad RF: Inhibition of human cyto-megalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA. Antimicrob Agents Chemother 40: 2004-2011, 1996
13. Crooke ST: Therapeutic applications of oligonucleotides. Ann Rev Pharmacol Toxicol 32: 329-376, 1992
14. Shakin-Eshleman SH, Liebhaber SA: Influence of duplexes 3 to the mRNA initiation codon on the efficiency of monosome formation. Biochemistry 27: 3975-3982, 1988
15. Daaka Y, Wickstrom E: Target dependence of antisense oligodeoxy-nucleotide inhibition of c-Ha-ras p21 expression and focus formation in T24-transformed NIH3T3 cells. Oncogene Res 5: 267-275, 1990
16. Tullis RH, Bryan RN, Mackedonski V: Oligonucleotides as specific translation inhibitors. J Cell Biochem Suppl 8A: 58 (Abstract), 1984
17. Liebhaber SA, Cash F, Eshelman SS: Translational inhibition by an mRNA coding region secondary structure is determined by its proximity to the AUG initiation code. J Mol Biol 226: 609-621, 1992
18. Blake KR, Murakami A, Spitz SA, Glave SA, Parameswara Reddy M, Ts'o POP, Miller PS: Hybridization arrest of globin synthesis in rabbit reticulocyte lysates and cells by oligodeoxyribonucleoside methylphosphonates. Biochemistry 24: 6139-6145, 1985
19. Helene C, Thuong NT: Control of gene expression by oligonucleotides covalently linked to intercalating agents. Genome 31: 413-421, 1989
20. Wagner R, Nishikura K: Cell cycle expression of RNA duplex unwinding activity in cells. Mol Cell Biol 8: 770-777, 1988
21. Loke S, Stein C, Zhang X, Mori K, Nakanishi M, Subashinge C, Cohen J, Neckers L: Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA 86: 3474-3478, 1989
22. Yakubov LA, Deeva EA, Zarytova VF, Ivanova EM, Ryte AS, Yurchenko LV, Vlassov VV: Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc Natl Acad Sci USA 86: 6454-6458, 1989
23. Verspieren P, Cornelissen AWCA, Thoung NT, Helene C, Toulme JJ: An acridine-linked oligodeoxynucleotide targeted to the common 5 end of trypanosome mRNAs kills culture parasites. Gene 61: 307-315, 1987
24. Marcus-Sekura C, Woerner A, Shinozuka K, Zon G, Quinnan G: Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl triester, methyl phosphonate and phosphorothioate linkages. Nucleic Acids Res 15: 5749-5763, 1987
25. Cazenave C, Stein C, Loreau N, Thuong N, Neckers L, Subashinghe C, Hélène C, Cohen J, Toulmé J: Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides. Nucleic Acid Res 17: 4255-4273, 1989
26. Bennett MR, Schwartz SM: Antisense therapy for angioplasty restenosis some critical considerations. Circulation 92: 1981-1993, 1995
27. Gao WY, Stein CA, Cohen JS: Effect of phosphorothioate homo-oligodeoxy nucleotides on herpes simplex virus type 2-induced DNA polymerase. J Biol Chem 264: 11521-11526, 1989
28. Agrawal S, Temsamani J, Golbrsith Wand Tang J: Pharmacokinetics of antisense oligonucleotides. Clin Pharma 28: 7-16, 1995
29. Edelman ER, Simons M, Sirois MG, Rosenberg RD: c-myc in vasculoproliferative disease. Circ Res 76: 176-182, 1995
30. Chonn A, Cullis PR: Recent advances in liposomal drug-delivery systems. Curr Opin Biotechnol 6: 698-708, 1995
31. Wang S, Lee RJ, Cauchon G, Gorenstein DG, Low PS: Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc Natl Acad Sci USA 92: 3318-3322, 1995
32. Mishra RK, Moreau C, Ramazeilles C, Moreau S, Bonnet J, Toulme JJ: Improved leishmanicidal effect of phosphorotioate anti sense oligonucleotdies by LDL mediated delivery. Biochim Ciphys Acta 1264: 229-237, 1995
33. Lu XM, Fischman AJ, Jyawook SL, Hendricks K, Tompkins RG, Yarmush ML: Antisense DNA delivery in vivo: liver targeting ybt receptor-mediated uptake. J Hucl Med 35: 269-275, 1994
34. Walker I, Irwin WJ, Akhtar S: Improved cellular delivery of antisense oligonucleotides using transferrin receptor antibody-oligonucleotide conjugates. Pharm Res 12: 1548-1553, 1995
35. 3H]-biotinylated phosphorothioate oligodeoxy-nucleotide conjugated to a vector-mediated drug delivery system. J Pharmacol Exp Ther 276: 206-211, 1996
36. Pardridge WM, Boado RJ, Kang YS: Vector-mediated delivery of a polyamide ('peptide') nucleic acid analogue through the blood-brain barrier in vivo. Proc Natl Acad Sci USA 92: 5592-5596, 1995
37. 1 receptors: a review. Immunopharmacology 30: 1-26, 1995
38. Uhlmann E, Peyman A: Antisense oligonucleotides: A new therapeutic principle. Chem Rev 90: 544-584, 1990
39. Gobeil F, Pheng LH, Badini I, Nguyen XK, Pizard A, Rizzi A, Blouin D, Regoli D: Receptors for kinins in umbilical human vessels. Br J Pharmacol 118: 289-294, 1996
40. Arïens E: Molecular Pharmacology, Academic Press, London, 1964
41. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fuduroda T, Fukami T, Ozaki S, Nagase T et al.: Biochemical and pharmacological profile of apotent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci (USA) 91: 4892-4896, 1994
42. Ihara M, Noguchi K, Saek T, Fukuroda T, Tsuchida S, Kimura S, Fukami T, Ishikawa K, Nishikibe M, Yano M: Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sciences 50: 247-255, 1992
43. Drapeau G, Regoli D: Synthesis of bradykinin analogues. Meth Enzymol 163: 263-272, 1988
44. 1 receptors for kinins in the rabbit by a bacterial lypopolysaccharide. Eur J Pharmacol 71: 105-115, 1981
45. 1 in rats by a lipopolysaccharide. Can J Physiol Pharmacol 74: 337-340, 1996
46. 1 bradykinin receptor. J Biol Chem 269: 21583-21586, 1994
47. Masaki T: Possible role of endothelin in endothelial regulation of vascular tone. Ann Rev Pharmacol Toxicol 35: 235-255, 1995
48. A receptor antisense oligodeoxynucleotides inhibit endothelin-1 evoked vasoconstriction. Eur J Pharmacol 261: 281-284, 1994
49. B-mediated pressor response in the pithed rat. J Cardiovasc Pharmacol 26: S219-S221, 1995
50. B receptors mediating constriction and relaxation? J Cardiovasc Pharmacol 26: supp. 3: 262-264, 1994
51. Wahlestedt C: Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol Sci 15: 42-46, 1994
52. Zamecnik PC, Stephenson ML: Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci USA 75: 280-284, 1978
53. Wickstrom EL, Wickstrom E, Lyman GH, Freeman DL: HL60 cell proliferation inhibited by an anti-c-myc pentadecaoxynucleotide (Abstract). Fed Proc 45: 1708, 1986
54. Simons M, Rosenberg RD: Antisense non-muscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res 70: 835-843, 1992
55. Thompson CB, Challoner PB, Neiman PE, Grondine M: Expression of the c-myb protooncogene during cellular proliferation. Nature 314: 363-366, 1985
56. Rabbitts T, Watson J, Lamond A, Forster A, Stinson M, Evan G, Fischer W, Athertton E, Sheppard M, Rabbitts T: Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J 4: 2009-2015, 1985
57. Morishita R, Gibbons G, Ellison KE, Nakajima M, von der Leyen H, Zhang L, Kaneda Y, Ogihara T, Dzau V: Intimal hyperplasia after vascular injury is inhibited by antisense cdk2 kinase oligonucleotides. J Clin Invest 93: 1458-1464, 1994
58. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA 90: 8474-8478, 1993
59. Simons M, Edelman ER, Rosenberg RD: Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model. J Clin Invest 93: 2351-2356, 1994
60. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM: PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 111: 2149-2158, 1990
61. Seifert RA, Hart CE, Phillips PE, Forstrom JW, Ross R, Murray MJ, Bowen-Pope DF: Two different subunits associate to create isoform-specific platelet derived growth factor receptors. J Biol Chem 264: 8771-8778, 1989
62. Koyama N, Hart CE, Clowes AW: Different functions of the platelet-derived growth factor-a and -b receptors for the migration and proliferation of cultured baboons smooth muscle cells. Circ Res 75: 682-691, 1994
63. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW: Platelet derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 89: 507-511, 1992
64. Langer R, Brown L, Edelman ER: Controlled release and magnetically modulated release systems for macromolecules. Meth Enzymol 112: 399-422, 1985
65. Gadeau A-P, Campna M, Desgranges C: Induction of cell cycle-dependent genes during cell cycle progression of arterial smooth muscle cells in culture. J Cell Physiol 146: 356-361, 1991
66. Luscher B, Eisenman R: New light on myc and myb, I: myc. Genes Dev 4: 2025-2035, 1990
67. Burgess TL, Fisher EF, Ross SL, Bready JV, Qian Y-X, Bayewitch LA, Cohen AM, Herrara CJ, Hu SS-F, Kramer TB, Lott FD, Martin FH, Pierce GF, Simonet L, Farrell CL: The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a non-antisense mechanism. Proc Natl Acad USA 92: 4051-4055, 1995
68. Guvakova MA, Yakubov LA, Vlodavsky I, Tonkinson JL, Stein CA: Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J Biol Chem 270: 2620-2627, 1995
69. Stein CA: Does antisense exist? Nature Med 1: 1119-1121, 1995
70. Wang A, Creasey A, Lardner M, Lin L, Strickler J, Van Arsdell J, Yamamoto R,Mark D: Molecular cloning of the complementary DNA for the human tumor necrosis factor. Science 228: 149-154, 1985
71. Holt JT, Redner RL, Nienhuis AW: An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol 8: 963-973, 1988
72. Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI: Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest 93: 820-828, 1994
73. Sirois MG, Simons M, Edelman ER, Kuter DJ, Rosenberg RD: Platelet release of platelet-derived growth factor is required for intimal hyperplasia in rat vascular model injury. Circulation 90:I-S11, 1994
74. Green PJ, Pines O, Inouye M: The role of antisense RNA in gene regulation. Ann Rev Biochem 55: 596-597, 1986
75. Kurihara Y, Kurihara H, Suzuki H, Komada T, MaemuraK, Nagai R, Oda H, Kuwaki T, Cao W, Kamada N, Jishage K, Ouchi Y, Azuma S, Toyoda Y, Ishikawa T, Kumada M, Yazaki Y: Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368: 703-710, 1994
76. Baird PN, D'Andrea RJ, Goodall GJ: Cytokine receptor genes: structure, chromosomal location, and involvement in human disease. Leukemia & Lymphoma 18: 373-383, 1995
77. Schinke M, Böhm M, Bricca G, Lippoldt A, Bader M, Ganten D: Antisense rna expression modulates angiotensinogen synthesis in cell culture and in the brain of transgenic rats. Hypertension 29: 508-513, 1996